An interventional study of PEEP 5 mbar and ZEEP 0 mbar in Ventilation Therapy, PEEP, Occult and CPR, sponsored by Muehlenkreiskliniken, MKK. Recruiting at 3 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-06.
Sponsored by Muehlenkreiskliniken, MKK · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Heart Arrest with a site in Germany — 8 open to participants now, 10 under way, none of them phase 3. Heart Arrest · Germany.
Among the 38 studies in Heart Arrest with a site in Germany, this one is the 4th largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 34th registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →8 of the 38 studies in Heart Arrest with a site in Germany are open now. Recruiting first, the newest first:
neurescue · Sites in Germany
Ages 18–80
University Hospital, Ghent · Sites in Germany, Austria, Belgium and 5 more countries
Ages 18+
Lund University · Sites in Germany, Finland, Sweden
Ages 18–100
Leipzig Heart Science gGmbH · Sites in Germany
Ages up to 18
University Hospital Freiburg · Sites in Germany
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 100 across 519 interventional studies indexed under Heart Arrest.
Median enrollment 150 across the 23 interventional studies, 200 across the 15 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 38 have an industry lead sponsor. The 10 most frequent:
Muehlenkreiskliniken, MKK is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Muehlenkreiskliniken, MKK has 2 studies filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
4 of the studies in Heart Arrest with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07579390Helsinki University Central HospitalEffects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) | 2026-12 |
| NCT07026773University Hospital, GhentValidity of ICU Clinician's Appraisal of Proportionality in CPR | 2026-12-30 |
| NCT06793033neurescueA Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support | 2027-01 |
| NCT07607808University Hospital, AachenPsychological Stress and Support Needs of Volunteer First Responders After Smartphone-based Cardiac Arrest Alerts | 2027-05-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 38 studies in Heart Arrest with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Out-of-hospital cardiac arrest (OHCA) remains a major cause of mortality, with low survival probabilities to hospital discharge. Despite the frequent use of airway management and mechanical ventilation during resuscitation, there is limited evidence regarding the optimal ventilation strategy to improve oxygen delivery and patient outcomes. The present study aims to investigate the effects of positive-end-expiratory-pressure (PEEP) set at 5 mbar compared to zero-end-expiratory-pressure (ZEEP) on the return of spontaneous-circulation (ROSC) in adult patients with OHCA.
This is a prospective, multicenter, cluster-randomized controlled trial conducted across emergency medical services (EMS) in the regions of Guetersloh, Minden-Luebbecke and Osnabrueck. Adult patients (>= 18 years) with OHCA who are undergoing mechanical ventilation through an airway device will be enrolled. The clusters (regional district) will be randomized into two groups: one group will receive ventilation with PEEP set at 5 mbar (intervention group), while the other group will receive ventilation with ZEEP (control group). The study's primary endpoint is the rate of ROSC. Secondary endpoints include rate of re-arrest, death during pre-hospital care phase, hospital admission during ongoing resuscitation, hospital admission with spontaneous circulation, peripheral oxygen saturation and end tidal CO2 at hospital admission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
PEEP Group (Intervention Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 5 mbar (PEEP).
Procedure: PEEP 5 mbar
ZEEP Group (Control Group): Patients will receive mechanical ventilation with end-expiratory-pressure set at 0 mbar (ZEEP).
Procedure: ZEEP 0 mbar
Positiv-End-Expiratory Pressure
Zero-End-Expiratory Pressure
The return of spontaneous circulation (ROSC)
The primary outcome is the ROSC, defined according to the Utstein template by the presence of a palpable pulse during or after resuscitation. This will be measured as a binary outcome (palpable pulse, yes or no).
Time frame: During or after resuscitation
Re-Arrest-Rate
Any need for chest compressions after ROSC (yes vs. no)
Time frame: Upon hospital admission
Death during pre-hospital care phase
Any death during pre-hospital care phase (yes vs. no)
Time frame: Upon hospital admission
Hospital admission during ongoing resuscitation
Need for chest-compressions at hospital admission (yes vs. no)
Time frame: at hospital admission
Hospital admission with spontaneous circulation
Hospital admission with spontaneous circulation without need for chest compressions (yes vs. no)
Time frame: at hospital admission
SpO2 at hospital admission
SpO2 at hospital admission (%)
Time frame: at hospital admission
FiO2 at hospital admission
FiO2 at hospital admission (%)
Time frame: at hospital admission
Plan to share: Undecided
Started Jun 2025 (actual). Primary completion is estimated for Jun 2026, 12 months after the start.
Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's planned 12 months is below that.
Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Muehlenkreiskliniken, MKK